Journal of Neurology

Papers
(The H4-Index of Journal of Neurology is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Impact of COVID-19 lockdown on sleep quality in university students and administration staff390
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms258
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases242
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)195
Stroke in patients with SARS-CoV-2 infection: case series170
A systematic review of neurological symptoms and complications of COVID-19160
COVID-19-associated acute disseminated encephalomyelitis (ADEM)151
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients138
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex120
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis108
The advances of post-stroke depression: 2021 update106
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?102
Acute transverse myelitis after COVID-19 pneumonia97
Neurological and cognitive sequelae of Covid-19: a four month follow-up95
Neurological manifestations associated with COVID-19: a review and a call for action89
First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease89
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study87
Rituximab for the treatment of multiple sclerosis: a review83
Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-1979
COVID-19 mRNA vaccination leading to CNS inflammation: a case series76
Neurological involvement of coronavirus disease 2019: a systematic review76
A review of seizures and epilepsy following traumatic brain injury74
Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy73
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment72
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials71
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study70
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient68
Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine68
Bell’s palsy following COVID-19 vaccination66
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region64
Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature64
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera64
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review61
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients60
Treatment of MOG antibody associated disorders: results of an international survey60
Digital therapeutics in neurology60
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation59
Impact of the COVID-19 outbreak on acute stroke care59
Association of CNS demyelination and COVID-19 infection: an updated systematic review58
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up57
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine56
COVID-19 in teriflunomide-treated patients with multiple sclerosis53
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms53
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study52
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential51
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-1951
Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)51
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung50
Managing disorders of consciousness: the role of electroencephalography50
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review50
0.044996976852417